DEI | Ticker Profile - Titan Protect

DEI

Douglas Emmett, Inc.

Real Estate · REIT - Office · NYQ

$12.20

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.3B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-106.37

Based on estimated future earnings — lower means cheaper

Rev Growth

-0.2%

Year-over-year revenue change

Profit Margin

-2.6%

How much profit the company keeps from each dollar of revenue

ROE

-1.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$12.50

+2% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 10 analysts covering this stock

About Douglas Emmett, Inc.

Douglas Emmett, Inc. is a fully integrated, self-administered and self-managed real estate investment trust , and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities. Douglas Emmett, Inc. was incorporated in 1971 and is based in Santa Monica, United States.

https://www.douglasemmett.com

Country: United States Employees: 778 Industry: REIT - Office

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.154

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0009

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.007

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-0.3%

Historical annualised return based on price data

Max Drawdown

-51.8%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.17

Moves slightly more than the broader market

52W High

$16.99

28% below the year high

52W Low

$9.04

35% above the year low

Avg Volume

2,502,078

Average daily shares traded — higher means easier to buy and sell

Short Ratio

11.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

27.9%

Very high short interest — potential squeeze candidate

Div Yield

660.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.17

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

162.63

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.39

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.36

Like current ratio but excludes inventory — stricter test

Gross Margin

63.2%

Revenue left after cost of goods — higher means pricing power

Operating Margin

19.5%

Profit from core operations before interest and tax

Free Cash Flow

$386M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.0B

Total revenue over the last 12 months

Net Income

$-27,506,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$15.00

Target Median

$12.50

Target Low

$11.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go